Log In
Print
BCIQ
Print
Print this Print this
 

Bronchozym, PulmoXen

  Manage Alerts
Collapse Summary General Information
Company Pharmsynthez JSC
DescriptionInhaled polysialylated recombinant human deoxyribonuclease I (DNase I) using PolyXen delivery technology
Molecular Target DNA
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPhase I
Standard IndicationCystic fibrosis (CF)
Indication DetailsTreat cystic fibrosis (CF)
Regulatory Designation

Partner

Xenetic Biosciences Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today